Filing Details

Accession Number:
0001773751-24-000305
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-23 16:35:41
Reporting Period:
2024-09-20
Accepted Time:
2024-09-23 16:35:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773751 Hims & Hers Health Inc. HIMS Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837796 Andrew Dudum 2269 Chestnut Street, #523
San Francisco CA 94123
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-09-20 42,099 $16.29 70,683 No 4 S Direct
Class A Common Stock Disposition 2024-09-20 3,668 $16.78 67,015 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 1,315,881 Indirect Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 795,490 Indirect Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock 1,675,943 Indirect Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock 534,491 Indirect Held by Trustee of AD 2022 GRAT
Class A Common Stock 570,398 Indirect Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 418,986 Indirect Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock 1,584,506 Indirect Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock 891,735 Indirect Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock 1,500 Indirect Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
Class A Common Stock 2,874,769 Indirect Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.
  2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.765 - $16.74. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.76 - $16.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.